Trazodone and ejaculatory inhibition

Kenneth R. Kaufman; Matthew Menza

doi:10.1080/00926230701267860

Trazodone and ejaculatory inhibition

Kenneth R. Kaufman, Matthew Menza

Rutgers, The State University

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

Sexual adverse effects are common with psychotropics. Rational polypharmacy may confound etiology. This case report describes development of ejaculatory inhibition in a male patient with co-morbid psychiatric diagnoses treated with fluoxetine, divalproex sodium, lamotrigine, trazodone, and clonazepam. Detailed psychotropic history with time-line of adverse effect onset implicated trazodone. Within 48 hours of trazodone discontinuation, ejaculatory inhibition was resolved. Clinicians should be aware that trazodone may cause ejaculatory inhibition, understand that determination of sexual adverse effects necessitates directed and periodic questioning as these symptoms may increase in severity over time, and appreciate that religious patients may find discussing this issue difficult.

Original language	American English
Pages (from-to)	225-230
Number of pages	6
Journal	Journal of Sex and Marital Therapy
Volume	33
Issue number	3
DOIs	https://doi.org/10.1080/00926230701267860
State	Published - May 2007

ASJC Scopus subject areas

Clinical Psychology

Access to Document

10.1080/00926230701267860

Cite this

@article{5eeb9ab9b7f340a3bdf48f49b2335b2c,

title = "Trazodone and ejaculatory inhibition",

abstract = "Sexual adverse effects are common with psychotropics. Rational polypharmacy may confound etiology. This case report describes development of ejaculatory inhibition in a male patient with co-morbid psychiatric diagnoses treated with fluoxetine, divalproex sodium, lamotrigine, trazodone, and clonazepam. Detailed psychotropic history with time-line of adverse effect onset implicated trazodone. Within 48 hours of trazodone discontinuation, ejaculatory inhibition was resolved. Clinicians should be aware that trazodone may cause ejaculatory inhibition, understand that determination of sexual adverse effects necessitates directed and periodic questioning as these symptoms may increase in severity over time, and appreciate that religious patients may find discussing this issue difficult.",

author = "Kaufman, \{Kenneth R.\} and Matthew Menza",

year = "2007",

month = may,

doi = "10.1080/00926230701267860",

language = "American English",

volume = "33",

pages = "225--230",

journal = "Journal of Sex and Marital Therapy",

issn = "0092-623X",

publisher = "Routledge",

number = "3",

}

TY - JOUR

T1 - Trazodone and ejaculatory inhibition

AU - Kaufman, Kenneth R.

AU - Menza, Matthew

PY - 2007/5

Y1 - 2007/5

N2 - Sexual adverse effects are common with psychotropics. Rational polypharmacy may confound etiology. This case report describes development of ejaculatory inhibition in a male patient with co-morbid psychiatric diagnoses treated with fluoxetine, divalproex sodium, lamotrigine, trazodone, and clonazepam. Detailed psychotropic history with time-line of adverse effect onset implicated trazodone. Within 48 hours of trazodone discontinuation, ejaculatory inhibition was resolved. Clinicians should be aware that trazodone may cause ejaculatory inhibition, understand that determination of sexual adverse effects necessitates directed and periodic questioning as these symptoms may increase in severity over time, and appreciate that religious patients may find discussing this issue difficult.

AB - Sexual adverse effects are common with psychotropics. Rational polypharmacy may confound etiology. This case report describes development of ejaculatory inhibition in a male patient with co-morbid psychiatric diagnoses treated with fluoxetine, divalproex sodium, lamotrigine, trazodone, and clonazepam. Detailed psychotropic history with time-line of adverse effect onset implicated trazodone. Within 48 hours of trazodone discontinuation, ejaculatory inhibition was resolved. Clinicians should be aware that trazodone may cause ejaculatory inhibition, understand that determination of sexual adverse effects necessitates directed and periodic questioning as these symptoms may increase in severity over time, and appreciate that religious patients may find discussing this issue difficult.

UR - https://www.scopus.com/pages/publications/34047224398

UR - https://www.scopus.com/inward/citedby.url?scp=34047224398&partnerID=8YFLogxK

U2 - 10.1080/00926230701267860

DO - 10.1080/00926230701267860

M3 - Article

C2 - 17454520

SN - 0092-623X

VL - 33

SP - 225

EP - 230

JO - Journal of Sex and Marital Therapy

JF - Journal of Sex and Marital Therapy

IS - 3

ER -

Trazodone and ejaculatory inhibition

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this